Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2024) 2024 heart disease and stroke statistics: a report of us and global data from the American Heart Association. Circulation 149(8):e347–e913

Article  PubMed  Google Scholar 

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118(17):3272–3287

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 79(17):e263–e421

Article  PubMed  Google Scholar 

Gilotra NA, Griffin JM, Pavlovic N, Houston BA, Chasler J, Goetz C et al (2022) Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review. J Card Fail 28(1):113–132

Article  PubMed  Google Scholar 

Gulati V, Harikrishnan P, Palaniswamy C, Aronow WS, Jain D, Frishman WH (2014) Cardiac involvement in hemochromatosis. Cardiol Rev 22(2):56–68

Article  PubMed  Google Scholar 

Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344(7):501–509

Article  PubMed  CAS  Google Scholar 

Morrissey RP, Philip KJ, Schwarz ER (2011) Cardiac abnormalities in Anderson–Fabry disease and Fabry’s cardiomyopathy. Cardiovasc J Afr 22(1):38–44

PubMed  PubMed Central  CAS  Google Scholar 

Shah KB, Inoue Y, Mehra MR (2006) Amyloidosis and the heart: a comprehensive review. Arch Intern Med 166(17):1805–1813

Article  PubMed  CAS  Google Scholar 

Nandy S, Hajra A, Bandyopadhyay D, Malik A, Mankad R, Grogan M et al (2023) Trends in the prevalence of infiltrative cardiomyopathy among patients with in-hospital cardiac arrest. Curr Probl Cardiol 48(10):101819

Article  PubMed  Google Scholar 

Kottam A, Hanneman K, Schenone A, Daubert MA, Sidhu GD, Gropler RJ et al (2023) State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association. Circ Cardiovasc Imaging 16(11):e000081

Article  PubMed  Google Scholar 

Writing Committee M, Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA et al (2024) 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines. J Am Coll Cardiol 83(23):2324-2405.

Article  Google Scholar 

Kligfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock EW et al (2007) Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 49(10):1109–1127

Article  PubMed  Google Scholar 

Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53(11):992–1002

Article  PubMed  Google Scholar 

Mason JW, Hancock EW, Gettes LS, Bailey JJ, Childers R, Deal BJ et al (2007) Recommendations for the standardization and interpretation of the electrocardiogram: part II: electrocardiography diagnostic statement list a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 49(10):1128–1135

Article  PubMed  Google Scholar 

Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53(11):982–991

Article  PubMed  Google Scholar 

Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53(11):976–981

Article  PubMed  Google Scholar 

Wagner GS, Macfarlane P, Wellens H, Josephson M, Gorgels A, Mirvis DM et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53(11):1003–1011

Article  PubMed  Google Scholar 

Bokhari SRA, Zulfiqar H, Hariz A (2024) Fabry disease. StatPearls, Treasure Island

Google Scholar 

Ng MS, Malacova E, Hurst C, Johnson DW, Mallett AJ (2021) Clinical outcomes of people with Fabry disease—ANZDATA registry study. Kidney Int Rep 6(9):2481–2485

Article  PubMed  PubMed Central  Google Scholar 

Bishop DF, Kornreich R, Desnick RJ (1988) Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3′ untranslated region. Proc Natl Acad Sci USA 85(11):3903–3907

Article  PubMed  PubMed Central  CAS  Google Scholar 

Andrade J, Waters PJ, Singh RS, Levin A, Toh BC, Vallance HD et al (2008) Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. Clin J Am Soc Nephrol 3(1):139–145

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR et al (2019) 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 74(7):e51–e156

Article  PubMed  Google Scholar 

Namdar M (2016) Electrocardiographic changes and arrhythmia in Fabry disease. Front Cardiovasc Med 3:7

Article  PubMed  PubMed Central  Google Scholar 

Gilstrap LG, Dominici F, Wang Y, El-Sady MS, Singh A, Di Carli MF et al (2019) Epidemiology of cardiac amyloidosis-associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States. Circ Heart Fail 12(6):e005407

Article  PubMed  PubMed Central  Google Scholar 

Ruiz-Hueso R, Salamanca-Bautista P, Quesada-Simon MA, Yun S, Conde-Martel A, Morales-Rull JL et al (2023) Estimating the prevalence of cardiac amyloidosis in old patients with heart failure-barriers and opportunities for improvement: the PREVAMIC study. J Clin Med 12(6):2273

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shams P, Ahmed I (2024) Cardiac amyloidosis. StatPearls, Treasure Island

Google Scholar 

Escher F, Senoner M, Doerler J, Zaruba MM, Messner M, Mussner-Seeber C et al (2020) When and how do patients with cardiac amyloidosis die? Clin Res Cardiol 109(1):78–88

Article  PubMed  CAS  Google Scholar 

Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P et al (2013) Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 106(10):528–540

Article  PubMed  Google Scholar 

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12(9):e006075

Article  PubMed  PubMed Central  Google Scholar 

Cheng Z, Zhu K, Tian Z, Zhao D, Cui Q, Fang Q (2013) The findings of electrocardiography in patients with cardiac amyloidosis. Ann Noninvasive Electrocardiol 18(2):157–162

Article  PubMed  Google Scholar 

Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126(10):1286–1300

Article  PubMed  PubMed Central